Alnylam Pharmaceuticals Inc (ALNY)
268.46
-2.56
(-0.94%)
USD |
NASDAQ |
Mar 28, 16:00
268.28
-0.18
(-0.07%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap: 34.75B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Pfizer Inc | 142.87B |
BridgeBio Pharma Inc | 6.678B |
Biomarin Pharmaceutical Inc | 13.63B |
Regeneron Pharmaceuticals Inc | 69.68B |
Vertex Pharmaceuticals Inc | 126.52B |
Market Cap Related Metrics
PS Ratio | 15.24 |
Price to Book Value | 518.04 |
Price | 268.46 |
Earnings Yield | -0.81% |